查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363510

生物植入物市场规模、型态和趋势分析报告：按产品、按给药、按用途、按地区和细分趋势，2023-2030

Biological Implants Market Size, Share & Trends Analysis Report By Product (Autografts, Allografts), By Mode of Administration (Surgical, Injectable), By Application (Cardiovascular Implants), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 147 Pages | 商品交期: 2-10个工作天内

价格

生物植入物市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球生物植入物市场规模将达到136.1亿美元，2023年至2030年年复合成长率为7.2%。

生物植入物市场受到各种临床用途（包括心血管、整形外科和其他软组织修復）的重组手术中越来越多地采用移植物和器官替代的推动。使用这些产品的主要挑战是采用能够特异性适应周围环境生物学以促进再生和修復的材料。为了克服这项挑战，人们正在努力从生物来源开发此类设备，从而影响未来的工业成长。

复合材料移植製程的改进有望透过带来整个移植过程的进步，在解决断指再植入问题上发挥重要作用。此外，该市场主要参与企业之间日益激烈的竞争是加速成长的影响要素之一。

生物植入物市场报告亮点

  • 根据移植物来源或供体，提供的产品分为自体移植物、同种异体移植物和异质骨移植。到 2022 年，异质骨移植将占销售额的 50% 以上。然而，同种异体移植物源自同一物种，发生异物免疫移植反应的机率要低得多，这会影响采用率，预计会快速增长。
  • 生物製药有多种用途，包括心血管、整形外科和其他软组织植入物。由于牙科领域产品的高使用率，软组织产品在 2022 年占据最大份额。儘管心血管植入物在当前情况下的普及最低，但对生物来源的心血管支架和瓣膜的需求预计将增长，从而增加该细分收益。
  • 据估计，手术给药在手术给药和注射给药中所占比例最大。手术植入微创技术的引入也是促进该细分市场成长的关键要素之一。
  • 北美地区由于市场参与企业广泛且人们的意识层级较高，以50.3%的销售份额占据市场主导地位。
  • 亚太地区预计将在未来年度出现最快的成长，由于目标人口的存在和医疗基础设施的快速改善，将推动对组织工程产品和生物植入物的需求。
  • 该行业的一些主要公司包括 Medtronic、NuVasive, Inc、Stryker Corporation、Conmed Corporation、CryoLife、Edwards LifeSciences Corporation、Acelity、Integra LifeSciences Corporation、Allergan Plc、RTI Surgical、IOP Ophthalmics、Organogenesis Inc 、BioPolymer GmbO &Coris。 Therapeutics、Baxter International、Vericel、Aplhatec Spine Inc、Maxigen Biotech Inc、Auto Tissue Berlin GmbH、MiMedx Group, Inc.
  • 这些参与者正在製定各种业务策略，以提高各自的渗透率并提高其在市场中的影响力。这些策略包括透过参与新产品开发和联合活动来扩大地域范围，以获取更大的收益占有率。例如，2016 年 4 月，Stryker Corporation收购了Stanmore Implants Worldwide Limited。这使该公司能够为整形外科肿瘤外科医生提供差异化技术，预计将在预测期内推动成长。

目录

第1章调查方法和范围

第2章执行摘要

第3章生物植入物市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 生物植入市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章生物植入：按产品的估算和趋势分析

  • 生物植入市场：重点
  • 生物医学植入物市场：2022 年和 2030 年趋势和市场占有率分析
  • 自体移植物
  • 同种异体移植物
  • 异质骨移植

第5章生物植入物：按用途估算和趋势分析

  • 生物植入市场：重点
  • 生物医学植入物市场：2022 年和 2030 年趋势和市场占有率分析
  • 心血管植入物
  • 整形外科植入物
  • 其他软组织植入物

第6章生物植入物：按给药的估计和趋势分析

  • 生物植入市场：重点
  • 生物医学植入物市场：2022 年和 2030 年趋势和市场占有率分析
  • 外科手术
  • 注射

第7章生物植入市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的生物植入物市场：重点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Integra LifeSciences
    • NuVasive, Inc.
    • Edwards Lifesciences Corporation
    • Stryker
    • LifeCell International Pvt. Ltd.
    • Medtronic
    • Osteotec Limited
    • RTI Surgical
    • BioPolymer GmbH & Co KG
    • Johnson & Johnson Private Limited
    • Baxter
    • Vericel
    • ATEC Spine, Inc
    • Artivion, Inc
    • Maxigen Biotech Inc.
    • Implandata Ophthalmic Products GmbH
    • CONMED Corporation
    • AbbVie Inc.
    • BioTissue
    • Auto Tissue Berlin GmbH
    • MIMEDX Group, Inc.
    • Organogenesis Inc.
    • Smith+Nephew
Product Code: GVR-1-68038-270-9

Biological Implants Market Growth & Trends:

The global biological implants market size is expected to reach USD 13.61 billion by 2030, according to a new report by Grand View Research, Inc.., registering a CAGR of 7.2% from 2023 to 2030. Biological implant market is driven by rise in adoption of grafts and organ substitutes for reconstructive surgeries for various clinical applications such as cardiovascular, orthopedic and other soft tissue repair. The main challenge associated with the use of these products is to incorporate such a material that can specifically adapt to the biology of the surrounding environment in order to accelerate regeneration and repair. To overcome this challenge, research endeavors are carried out in order to develop such devices from biological source thus affecting industrial growth in the coming years.

Modification in the process of composite grafting is expected to play a crucial role in tackling reimplantation of amputated fingertips by bringing development in the overall process of grafting. Moreover, rising competition amongst key participants operating in this market is one of the high impact rendering factors to accelerate the growth.

Biological Implants Market Report Highlights:

  • Depending upon the source or donor of grafts, products offered can be categorized into autograft, allografts, and xenografts. Xenografts dominated the revenue share in 2022 with a revenue share of over 50%. However, allografts are expected to witness the fastest growth owing to the fact that they are derived from same species and produce considerably less chances of foreign immune implants reaction, thereby influencing adoption rate.
  • Biological serve various application domains which include cardiovascular, orthopedic, and other soft tissue implants. Soft tissue products accounted for the largest share in 2022 as a result of higher usage of the products in the field of dentistry. Even though cardiovascular implants accounted for lowest penetration in the current scenario, demand for cardiovascular stents and valves obtained from biological source is expected to expand, consequently boosting revenue generation from this segment.
  • Amongst surgical and injectable mode of administration, surgical mode is estimated to hold the larger share, as a consequence of availability of several products administered via this route. Introduction of minimally invasive techniques for surgical incorporation of grafts is also one of the significant factors propelling growth in this segment.
  • North America dominated the market with a revenue share of 50.3% due to widespread presence of participants coupled with high aesthetic and healthcare awareness levels amongst the population in this region.
  • Asia Pacific is estimated to exhibit the fastest growth in the coming years due to presence of the target population and rapidly improving health care infrastructure which is attributed to drive the demand for tissue engineered products and biological implants.
  • Major players operating in this industry include Medtronic, NuVasive, Inc, Stryker Corporation, Conmed Corporation, CryoLife, Edwards LifeSciences Corporation, Acelity, Integra LifeSciences Corporation, Allergan Plc, RTI Surgical, IOP Ophthalmics, Organogenesis Inc, BioPolymer GmbH & Co. KG, Osiris Therapeutics, Baxter International, Vericel, Aplhatec Spine Inc, Maxigen Biotech Inc, Auto Tissue Berlin GmbH, MiMedx Group, Inc., Biotissue Technologies,
  • These players are undertaking different business strategies to boost their respective penetration and enhance market presence. These strategies include novel product developments and geographic expansion by involving in collaborative activities in order to grab the larger share of revenue. For instance, in April 2016, Stryker Corporation acquired Stanmore Implants Worldwide Limited which is expected to enable the company to provide differentiated technologies to orthopedic oncology surgeons, thus propelling growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Mode of Administration
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Mode of administration outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Biological Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Biological Implants Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Biological Implants: Product Estimates & Trend Analysis

  • 4.1. Biological Implants Market: Key Takeaways
  • 4.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Autografts
    • 4.3.1. Autografts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Allografts
    • 4.4.1. Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Xenografts
    • 4.5.1. Xenografts market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Biological Implants: Application Estimates & Trend Analysis

  • 5.1. Biological Implants Market: Key Takeaways
  • 5.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Cardiovascular Implants
    • 5.3.1. Cardiovascular implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Orthopedic Implants
    • 5.4.1. Orthopedic implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Other Soft Tissue Implants
    • 5.5.1. Other soft tissue implants market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Biological Implants: Mode of Administration Estimates & Trend Analysis

  • 6.1. Biological Implants Market: Key Takeaways
  • 6.2. Biological Implants Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Surgical
    • 6.3.1. Surgical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Injectable
    • 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Biological Implants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Biological Implants Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Integra LifeSciences
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. NuVasive, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Edwards Lifesciences Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Stryker
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. LifeCell International Pvt. Ltd.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Osteotec Limited
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. RTI Surgical
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. BioPolymer GmbH & Co KG
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Johnson & Johnson Private Limited
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Baxter
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. Vericel
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. ATEC Spine, Inc
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Artivion, Inc
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Maxigen Biotech Inc.
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives
    • 8.2.16. Implandata Ophthalmic Products GmbH
      • 8.2.16.1. Company overview
      • 8.2.16.2. Financial performance
      • 8.2.16.3. Product benchmarking
      • 8.2.16.4. Strategic initiatives
    • 8.2.17. CONMED Corporation
      • 8.2.17.1. Company overview
      • 8.2.17.2. Financial performance
      • 8.2.17.3. Product benchmarking
      • 8.2.17.4. Strategic initiatives
    • 8.2.18. AbbVie Inc.
      • 8.2.18.1. Company overview
      • 8.2.18.2. Financial performance
      • 8.2.18.3. Product benchmarking
      • 8.2.18.4. Strategic initiatives
    • 8.2.19. BioTissue
      • 8.2.19.1. Company overview
      • 8.2.19.2. Financial performance
      • 8.2.19.3. Product benchmarking
      • 8.2.19.4. Strategic initiatives
    • 8.2.20. Auto Tissue Berlin GmbH
      • 8.2.20.1. Company overview
      • 8.2.20.2. Financial performance
      • 8.2.20.3. Product benchmarking
      • 8.2.20.4. Strategic initiatives
    • 8.2.21. MIMEDX Group, Inc.
      • 8.2.21.1. Company overview
      • 8.2.21.2. Financial performance
      • 8.2.21.3. Product benchmarking
      • 8.2.21.4. Strategic initiatives
    • 8.2.22. Organogenesis Inc.
      • 8.2.22.1. Company overview
      • 8.2.22.2. Financial performance
      • 8.2.22.3. Product benchmarking
      • 8.2.22.4. Strategic initiatives
    • 8.2.23. Smith+Nephew
      • 8.2.23.1. Company overview
      • 8.2.23.2. Financial performance
      • 8.2.23.3. Product benchmarking
      • 8.2.23.4. Strategic initiatives 

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 5 North America biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 9 Canada biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 12 Europe biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 15 Europe biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 19 UK biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 22 France biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 23 France biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 24 France biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 25 Italy biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 28 Spain biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 31 Sweden biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 34 Norway biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 37 Denmark biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 47 China biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 48 China biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 49 China biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 50 India biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 51 India biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 52 India biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 53 Australia biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 56 Thailand biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 57 Thailand biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 59 South Korea biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 62 Latin America biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 65 Latin America biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 69 Mexico biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 72 Argentina biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa biological implants market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 85 UAE biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE biological implants market, by mode of administration, 2018 - 2030 (USD Million)
  • Table 88 Kuwait biological implants market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait biological implants market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait biological implants market, by mode of administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Biological implants: Market outlook
  • Fig. 8 Biological implants: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Biological implants market driver impact
  • Fig. 14 Biological implants market restraint impact
  • Fig. 15 Biological implants market strategic initiatives analysis
  • Fig. 16 Biological implants market: Product movement analysis
  • Fig. 17 Biological implants market: Product outlook and key takeaways
  • Fig. 18 Autografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Allografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Xenografts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biological implants market: Application movement analysis
  • Fig. 22 Biological implants market: Application outlook and key takeaways
  • Fig. 23 Cardiovascular implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Orthopedic implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other soft tissue implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Biological implants market: Mode of administration movement analysis
  • Fig. 27 Biological implants market: Mode of administration outlook and key takeaways
  • Fig. 28 Surgical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Injectable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global biological implants market: Regional movement analysis
  • Fig. 31 Global biological implants market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)